Call for Abstracts: Molecular Pharming - Recent Progress in Manufacturing Medicines in Plants
Friday, 21 September 2012 09:00 - 17:00 London, United Kingdom
Molecular Pharming is on the brink of taking off! After two decades of development and academic proofs of principle, a number of recent advances have moved the technology rapidly towards commercialisation. The first products are now being licensed in the USA. The first-in-human clinical trial of a plant derived monoclonal antibody has been performed in Europe. And there has been significant investment into manufacturing facilities around the world.
This meeting will review the progress of the field, highlight major technological advances and scan the horizon for future developments.
The Deadline for abstract submissions for oral presentation is June 10th 2012
Abstracts for poster presentation only can be submitted up to two weeks before the event
Please note that there will be a best poster prize.
Contact Details
Email: enquiries@euroscicon.com
Web: www.euroscicon.com
For all accommodation and travel enquiries please contact accommodationandtravel@euroscicon.com
